Bo Qiu

2.5k total citations
134 papers, 1.7k citations indexed

About

Bo Qiu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Bo Qiu has authored 134 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pulmonary and Respiratory Medicine, 41 papers in Surgery and 33 papers in Oncology. Recurrent topics in Bo Qiu's work include Lung Cancer Diagnosis and Treatment (32 papers), Esophageal Cancer Research and Treatment (24 papers) and Lung Cancer Treatments and Mutations (19 papers). Bo Qiu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (32 papers), Esophageal Cancer Research and Treatment (24 papers) and Lung Cancer Treatments and Mutations (19 papers). Bo Qiu collaborates with scholars based in China, Hong Kong and United States. Bo Qiu's co-authors include Xia Huo, Liangkai Zheng, Xijin Xu, Lin Peng, Dai Hoon Han, Zhang Bao, Zhong-xian Piao, Zongli Qi, Hui Liu and C.W. Ogle and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Bo Qiu

120 papers receiving 1.7k citations

Peers

Countries citing papers authored by Bo Qiu

Since Specialization

Citations

This map shows the geographic impact of Bo Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Qiu more than expected).

Fields of papers citing papers by Bo Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Qiu. The network helps show where Bo Qiu may publish in the future.

Co-authorship network of co-authors of Bo Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Qiu. A scholar is included among the top collaborators of Bo Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Qiu. Bo Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial 2025 ·EClinicalMedicine ·(unknown), (unknown), (unknown), Sen Wei, (unknown), Mengru Wang, Hao Zhang, PengXin Zhang, (unknown), Shaohan Yin, Chuanmiao Xie, Yi Hu, Bo Qiu, Hui Liu	1
2	Early Nutritional Intervention in Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: A Phase II Prospective Study 2025 ·Nutrients ·(unknown), (unknown), (unknown), PengXin Zhang, (unknown), Suping Guo, (unknown), Daquan Wang, Qingping Wu, Hui Liu, Yuming Rong, Bo Qiu	0
3	Injectable Thymosin β4-Modified Hyaluronic Acid Hydrogel with Exosomes for Stem Cell Homing and Neuronic–Angiogenic–Osteogenic Coupled Cranial Repair 2025 ·ACS Nano ·Yanhai Xi, Zhen Zhang, Zixuan Zhao, Bo Qiu, Weiheng Wang, Guohua Xu, (unknown), Feng Shi, Wei Liang, Jun Wu	1
4	Efficacy and safety of online adaptive magnetic resonance-guided fractionated stereotactic radiotherapy for brain metastases in non-small cell lung cancer (GASTO-1075): a single-arm, phase 2 trial 2025 ·EClinicalMedicine ·(unknown), (unknown), (unknown), (unknown), Rui Zhou, PengXin Zhang, (unknown), Yimei Liu, (unknown), (unknown), Mengru Wang, Xiaoyan Huang, Shaohan Yin, Wenfeng Fang, (unknown), Bo Qiu, Daquan Wang, Hui Liu	0
5	Safety and Efficacy of Unresectable Malignant Cardiac Tumors Treated with Concurrent Chemoradiation Therapy Using a 1.5T MR-Linac (GASTO-1078) 2025 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Sandrine Ding, (unknown), (unknown), (unknown), (unknown), Yue-Ming Peng, Xiaoyan Huang, Bo Qiu, Yaobin Lin, (unknown), Mai Xiong	0
6	Cotinine exposure enhances the association of blood manganese and non-alcoholic fatty liver disease in American children: a cross-sectional study 2024 ·Scientific Reports ·Ping Zhang, Hua-xing Wei, Shihui Lin, Bo Qiu, (unknown)	0
7	A phase II randomized trial evaluating consolidative nivolumab in locally advanced non-small cell lung cancer post neoadjuvant chemotherapy plus nivolumab and concurrent chemoradiotherapy (GASTO-1091). 2024 ·Journal of Clinical Oncology ·Hui Liu, Bo Qiu, Yuanyuan Zhao, Wenzhuo He, Weineng Feng, (unknown), Jun Jia, Fanjun Meng, (unknown), (unknown), JinYu Guo, (unknown), Suping Guo, (unknown), (unknown), Jibin Li, Yunpeng Yang, Liangping Xia, (unknown)	3
8	Neoadjuvant toripalimab plus chemotherapy followed by concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (GASTO 1071). 2024 ·Journal of Clinical Oncology ·Bo Qiu, (unknown), (unknown), (unknown), (unknown), JinYu Guo, (unknown), (unknown), Guangyu Luo, Hui Liu	0
9	A randomized phase II study of toripalimab consolidation or observation after concurrent chemoradiotherapy in limited-stage small cell lung cancer. 2024 ·Journal of Clinical Oncology ·PengXin Zhang, (unknown), (unknown), (unknown), (unknown), (unknown), Ying Liang, Yuanyuan Zhao, Bo Qiu, Hui Liu	3
10	Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study 2024 ·Clinical Cancer Research ·(unknown), (unknown), (unknown), (unknown), PengXin Zhang, (unknown), (unknown), Li Chen, (unknown), (unknown), Yuming Rong, Hui Liu, Bo Qiu	3
11	Efficacy and influencing factor analysis of Voriconazole in the treatment of invasive fungal infections 2023 ·Diagnostic Microbiology and Infectious Disease ·(unknown), (unknown), (unknown), Ying Li, Bo Qiu	1
12	Role of TRPV1 in electroacupuncture‐mediated signal to the primary sensory cortex during regulation of the swallowing function 2023 ·CNS Neuroscience & Therapeutics ·(unknown), Bo Qiu, Ying Liang, (unknown), (unknown), Xiaorong Tang, (unknown), Sheng Zhou, (unknown), Hongzhu Li, (unknown), Lin Wang, Shuai Cui, Chunzhi Tang, Yi Wei, (unknown), Nenggui Xu	10
13	Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059) 2023 ·Cancer Medicine ·(unknown), (unknown), (unknown), Bo Qiu, Yujia Zhu, Lei Zhao, Mian Xi, (unknown), Suping Guo, JinYu Guo, (unknown), Daquan Wang, (unknown), (unknown), Yonghong Hu, Mengzhong Liu, (unknown), Hui Liu	2
14	Better preservation of erectile function in localized prostate cancer patients with modern proton therapy: Is it cost‐effective? 2022 ·The Prostate ·Guo Li, Yunfei Xia, Yixiang Huang, (unknown), Bo Qiu, J. Doyen, Pierre‐Yves Bondiau, Karen Bénézery, Jin Gao, Chao‐Nan Qian	2
15	Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Bo Qiu, Xi Yu, (unknown), Ying Li, Xinqiang Xie, JinYu Guo, Suping Guo, (unknown), Lei Wu, Tingting Liang, Yu Ding, Jumei Zhang, Qingping Wu, Hui Liu	15
16	Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination vs. Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1) 2021 ·Frontiers in Oncology ·Lin Wu, Chao Deng, Hui Zhang, Jie Weng, Youhua Wu, Shan Zeng, Tiegang Tang, Peiguo Cao, Bo Qiu, Li Zhang, Huaxin Duan, Bing Zhang, Dong Zhang, Taotao Zhang, Chunhong Hu	2
17	A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the Elderly 2021 ·Frontiers in Oncology ·Suping Guo, (unknown), Hui Liu, (unknown), Xuhui Zhang, (unknown), Guangyu Luo, Qiwen Li, (unknown), Nan Hu, (unknown), Jun Zhang, (unknown), Huixia Feng, Bo Qiu	2
18	<p>Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer</p> 2020 ·OncoTargets and Therapy ·Bo Qiu, Ling‐Yu Chu, (unknown), Yu‐Hui Peng, Yi‐Wei Xu, Jian‐Jun Xie, (unknown)	3
19	Combined Modalities of Magnetic Resonance Imaging, Endoscopy, and Computed Tomography in Evaluation of Tumor Response to Definitive Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Bo Qiu, (unknown), Hao‐Xian Yang, Wenjun Xie, Ying Liang, Pei Cai, (unknown), Jianhua Fu, (unknown), (unknown)	1
20	The effects of a low‐salt diet on the efficacy of different antihypertensive drug regimens 2015 ·The Journal of Clinical Pharmacology ·(unknown), Bo Qiu, Jianlin Du, Songbai Deng, (unknown), Qiang She	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact